Use of Dermoscopy to Diagnose and Select BCCs that can be Treated Empirically
- 37 Downloads
Purpose of Review
The diagnostic value of dermoscopy for basal cell carcinomas (BCCs) is well established. This paper aims to review available data on the role of dermoscopy not only in the management of BCCs in everyday practice and mainly in selecting tumors that may be treated non-surgically.
Several factors influence the selection of treatment for BCC, including the histopathologic subtype, tumor depth, the presence of pigmentation or ulceration, the anatomic site, and patient’s physical profile. Dermoscopy was shown to provide additional information to the naked eye examination about several of these parameters and, therefore, might be very helpful tool in the pre-operative and post-treatment evaluation of BCCs.
In addition to its well-documented value in diagnosis, dermoscopy also gains ground in management of BCC. By revealing features not clinically seen, dermoscopy is a useful guide that enhances the selection of the appropriate treatment strategy and the assessment of post-treatment response.
KeywordsBasal cell carcinoma Dermoscopy Management Treatment Non-ablative therapies
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.• Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88(2):167–79. This review article provides a thorough description of the pathogenetic, epidemiologic, clino-histopathologic features as well as the management options of BCC . PubMedPubMedCentralGoogle Scholar
- 2.• Bichakjian CK, Olencki T, Aasi SZ, et al. Basal cell skin cancer, Version 1.2016, NCCN Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14(5):574–97. This article provides recommendations and guidance for selecting the appropriate treatment choice of BCCs based on patient-, lesion-, and disease-specific factors . CrossRefPubMedGoogle Scholar
- 11.Pan Y, Chamberlain AJ, Bailey M, Chong AH, Haskett M, Kelly JW. Dermatoscopy aids in the diagnosis of the solitary red scaly patch or plaque-features distinguishing superficial basal cell carcinoma, intraepidermal carcinoma, and psoriasis. J Am Acad Dermatol. 2008;59(2):268–74.CrossRefPubMedGoogle Scholar
- 20.• Lallas A, Tzellos T, Kyrgidis A, Apalla Z, Zalaudek I, Karatolias A, et al. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma. J Am Acad Dermatol. 2014;70(2):303–11. This diagnostic accuracy study evaluated the dermoscopic criteria associated with different BCC subtypes. CrossRefPubMedGoogle Scholar
- 22.Themstrup L, De Carvalho N, Nielsen SM et al. In vivo differentiation of common basal cell carcinoma subtypes by microvascular and structural imaging using dynamic optical coherence tomography. Exp Dermatol 2017Google Scholar
- 38.• Apalla Z, Lallas A, Tzellos T, Sidiropoulos T, Lefaki I, Trakatelli M, et al. Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma. Br J Dermatol. 2014;170(4):809–15. This study suggests the utility of dermoscopy in the evaluation of treatment response and monitoring of sBCCs after nonablative therapies CrossRefPubMedGoogle Scholar